Symbols

Symbols

TIVC

TIVC

Tivic Health Refines Neurostimulation Parameters, Faces Financial Challenges

Monday Nov 10, 2025

Tivic Health shares rise 10.76% premarket after filing two new patents for cancer therapies and vagus nerve stimulation device.

Wednesday Sep 17, 2025

Thrive Capital's 15min chart sees KDJ Golden Cross, bullish Marubozu signal.

Saturday Aug 30, 2025

Tivic Health Files to Sell 1.59M Shares of Common Stock

Wednesday Aug 27, 2025

Tivic Health Systems Appoints New Transfer Agent: Odyssey Transfer and Trust Company

Thursday Aug 21, 2025

Tivic Health receives IND approvals from Statera Biopharma for Entolimod treatment of acute radiation syndrome and advanced cancers.

Friday Aug 15, 2025

Tivic Health Systems Reports Q2 2025 Earnings, Focuses on Prescription Therapeutics, Secures Exclusive License for TLR5 Agonist Platform, and Strengthens Cash Position.

Thursday Aug 14, 2025

Tivic Reports Q2 Financial Results, Advances TLR5 Agonist Program

Tivic Health Shifts Focus to Biopharmaceuticals, Advances Immunotherapy Pipeline

Tivic Health Systems Q2 2025 Revenue Down 39% Amidst Biopharmaceutical Shift

Saturday Aug 09, 2025

Tivic Health Registers 400K Shares for Resale Linked to Statera Biopharma License Agreement

Friday Aug 08, 2025

Tivic Health Registers 400K Shares for Resale Linked to Statera Biopharma License Agreement

Wednesday Jul 09, 2025

Nuwellis 15min chart shows Bollinger Bands Narrowing, Bearish Marubozu Formation

Tuesday Jul 08, 2025

Tivic Shareholders Approve Key Proposals for Biopharmaceutical Expansion; Lisa Wolf Appointed Permanent CFO

Tivic Health Systems Appoints Lisa Wolf as CFO, Blake Gurfein Transitions to Consultant Role

Tivic Appoints Lisa Wolf as Permanent CFO, Blake Gurfein Steps Down as CSO

Tivic Health Shareholders Approve Key Proposals for Strategic Transformation

Thursday Jun 26, 2025

Tivic Health Completes Key Study for Nerve Stimulation Device, Anticipates Phase I Clinical Trial

Wednesday Jun 25, 2025

Tivic Health Completes Optimization Study for Non-Invasive Vagus Nerve Stimulation Device.

Tuesday Jun 24, 2025

Tivic Health Announces 2025 Annual Meeting of Stockholders, to be held virtually on June 30, 2025.